Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer’s disease

Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer’s disease

Altered glycosylation profiles have been correlated with potential drug targets in various diseases, including Alzheimer’s disease (AD). In this area, the linkage between bisecting N-acetylglucosamine (GlcNAc), a product of N-acetylglucosaminyltransferase III (GnT-III), and AD has been recognized, h...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Yue Wang, Yixuan Du, Hongfei Huang, Yiming Cao, Kemeng Pan, Yueqian Zhou, Jiawei He, Wenbing Yao, Song Chen, Xiangdong Gao
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2024-04-01
Sraith:Pharmacological Research
Ábhair:
Alzheimer’s disease
Bisecting glycosylation
N-acetylglucosaminyltransferase III
Microglia
Intercellular adhesion molecule-1
Rochtain ar líne:http://www.sciencedirect.com/science/article/pii/S104366182400077X

Ar líne

http://www.sciencedirect.com/science/article/pii/S104366182400077X

Míreanna comhchosúla